These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 18363754

  • 1. A follow-up of four cases of nephrogenic systemic fibrosis: is gadolinium the specific trigger?
    Singh M, Davenport A, Clatworthy I, Lewin J, Deroide F, Hubbard V, Rustin MH.
    Br J Dermatol; 2008 Jun; 158(6):1358-62. PubMed ID: 18363754
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis.
    Abraham JL, Thakral C, Skov L, Rossen K, Marckmann P.
    Br J Dermatol; 2008 Feb; 158(2):273-80. PubMed ID: 18067485
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Gadolinium-induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury.
    Kalb RE, Helm TN, Sperry H, Thakral C, Abraham JL, Kanal E.
    Br J Dermatol; 2008 Mar; 158(3):607-10. PubMed ID: 18076707
    [Abstract] [Full Text] [Related]

  • 7. Nephrogenic systemic fibrosis: a serious iatrogenic disease of renal failure patients.
    Khurram M, Skov L, Rossen K, Thomsen HS, Marckmann P.
    Scand J Urol Nephrol; 2007 Mar; 41(6):565-6. PubMed ID: 17934986
    [Abstract] [Full Text] [Related]

  • 8. Quantification of gadolinium in nephrogenic systemic fibrosis: re-examination of a reported cohort with analysis of clinical factors.
    Khurana A, Greene JF, High WA.
    J Am Acad Dermatol; 2008 Aug; 59(2):218-24. PubMed ID: 18538448
    [Abstract] [Full Text] [Related]

  • 9. Extracellular Gd-CA: differences in prevalence of NSF.
    Thomsen HS, Marckmann P.
    Eur J Radiol; 2008 May; 66(2):180-3. PubMed ID: 18342468
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The evolution of osseous metaplasia in localized cutaneous nephrogenic systemic fibrosis: a case report.
    Wiedemeyer K, Kutzner H, Abraham JL, Thakral C, Carlson JA, Tran TA, Hausser I, Hartschuh W.
    Am J Dermatopathol; 2009 Oct; 31(7):674-81. PubMed ID: 19633532
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure.
    Othersen JB, Maize JC, Woolson RF, Budisavljevic MN.
    Nephrol Dial Transplant; 2007 Nov; 22(11):3179-85. PubMed ID: 17890246
    [Abstract] [Full Text] [Related]

  • 15. Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
    Grobner T.
    Nephrol Dial Transplant; 2006 Apr; 21(4):1104-8. PubMed ID: 16431890
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor.
    Moreno-Romero JA, Segura S, Mascaró JM, Cowper SE, Julià M, Poch E, Botey A, Herrero C.
    Br J Dermatol; 2007 Oct; 157(4):783-7. PubMed ID: 17627792
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Nephrogenic systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (omniscan).
    Khurana A, Runge VM, Narayanan M, Greene JF, Nickel AE.
    Invest Radiol; 2007 Feb; 42(2):139-45. PubMed ID: 17220732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.